cannabis indica

Índice completo — página 10 de 77

Estudos 901 a 1.000 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2022. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 901 a 1.000

  1. 2022

    Current Cannabidiol Safety: A Review

    FavorávelMetanáliseDorCâncerInflamação+11
  2. 2022

    Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology

  3. 2022

    Cys-loop receptors on cannabinoids: All high?

    FavorávelMetanáliseDorDor — CrônicaEpilepsia
  4. 2022

    D-limonene (5 (one-methyl-four-[1-methylethenyl]) cyclohexane) diminishes CCl4-induced cardiac toxicity by alleviating oxidative stress, inflammatory and cardiac markers

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)
  5. 2022

    Daily Consumption of Lemon and Ginger Herbal Infusion Caused Tumor Regression and Activation of the Immune System in a Mouse Model of Breast Cancer

    FavorávelEstudo em AnimaisCâncerCâncer — Mama
  6. 2022

    Decreasing sperm quality in mice subjected to chronic cannabidiol exposure: New insights of cannabidiol-mediated male reproductive toxicity

  7. 2022

    Deficiency of autism-related Scn2a gene in mice disrupts sleep patterns and circadian rhythms

    FavorávelEstudo em AnimaisAutismoCanabinoides Sintéticos HU-x
  8. 2022

    Delta-8-THC: Delta-9-THC’s nicer younger sibling?

    FavorávelMetanáliseDorEfeitos Adversos da CannabisDor — CrônicaDelta-8-THC
  9. 2022

    Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women

    DesfavorávelEnsaio Clínico Duplo-CegoTranstornos de ComportamentoTetraidrocanabinol (THC)
  10. 2022

    Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior

    FavorávelEnsaio Clínico Duplo-CegoDisfunção CognitivaPsicoseTranstornos de Comportamento
  11. 2022

    Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist

  12. 2022

    Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia

    FavorávelEstudo LaboratorialCondições GeriátricasSarcopeniaPalmitoiletanolamida (PEA)
  13. 2022

    Development and characterization of cannabidiol-loaded alginate copper hydrogel for repairing open bone defects in vitro

    FavorávelEstudo LaboratorialCicatrizaçãoFraturas Ósseas
  14. 2022

    Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database

  15. 2022

    Diagnostic significance of heart-type fatty acid-binding protein as a potential biomarker to predict the mortality rate of patients with sepsis: a systematic review and meta-analysis

    FavorávelMetanáliseSepseProteína Ligadora de Ácidos Graxos (FABP)
  16. 2022

    Dietary supplementation of hemp oil in teddy dogs: Effect on apparent nutrient digestibility, blood biochemistry and metabolomics

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoSíndrome Metabólica+3
  17. 2022

    Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder

  18. 2022

    Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies

  19. 2022

    Different Cytotoxic Effects of Vetiver Oil on Three Types of Cancer Cells, Mainly Targeting CNR2 on TNBC

    FavorávelEstudo LaboratorialCâncerCâncer — Mama
  20. 2022

    Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists

  21. 2022

    Differential Effects of D9 Tetrahydrocannabinol (THC)- and Cannabidiol (CBD)-Based Cannabinoid Treatments on Macrophage Immune Function In Vitro and on Gastrointestinal Inflammation in a Murine Model

  22. 2022

    Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model

    FavorávelEstudo em AnimaisSíndrome de DownAnandamida (AEA)Endocanabinoide (não especificado)+4
  23. 2022

    Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes

    InconclusivoMetanáliseEfeitos Adversos da CannabisDiabetesSíndrome Metabólica+1
  24. 2022

    Digital Help for Substance Users (SU): A Systematic Review

    InconclusivoMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Opioides+4
  25. 2022

    Disparity between Perceptual Fall Risk and Physiological Fall Risk in Older Cannabis Users: A Pilot Study

  26. 2022

    Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats

    FavorávelEstudo em AnimaisDiabetesSíndrome Metabólica
  27. 2022

    Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions

    InconclusivoMetanáliseDorAnsiedadeDor — AgudaAnandamida (AEA)Exercício Físico
  28. 2022

    Does body mass index explain the apparent anti-inflammatory effects of cannabis use? Results From a cohort study of sexual and gender minority youth

    FavorávelEnsaio ClínicoInflamação
  29. 2022

    Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

  30. 2022

    Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisPsicose
  31. 2022

    Does cannabis use impact cognitive behavioural therapy outcomes for anxiety and related disorders? A preliminary examination

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — Cannabis
  32. 2022

    Does cannabis use predict aggressive or violent behavior in psychiatric populations? A systematic review

    InconclusivoMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+5
  33. 2022

    Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply

  34. 2022

    Dopaminergic alterations in populations at increased risk for psychosis: A systematic review of imaging findings

    FavorávelMetanálise ClínicaPsicose
  35. 2022

    Dose-dependent alteration of neurobehavioral activities by geraniol a component of essential oil: A study in rats

    FavorávelEstudo em AnimaisAnsiedadeDepressãoEstresse Oxidativo
  36. 2022

    Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells

    FavorávelEstudo LaboratorialCâncerCâncer — MamaÁcido Canabidiólico (CBD-a)
  37. 2022

    Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model

    FavorávelEstudo em AnimaisInflamaçãoObesidadeSíndrome Metabólica+3
  38. 2022

    Driving Performance and Cannabis Users' Perception of Safety: A Randomized Clinical Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  39. 2022

    Dropout Rates in Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse: A Systematic Review and Meta-Analysis

    FavorávelMetanáliseDependência QuímicaPsicoseEsquizofrenia
  40. 2022

    Drug-drug interaction between cannabidiol and phenobarbital in healthy dogs

    FavorávelEstudo em AnimaisAplicações Veterinárias
  41. 2022

    Drugs of Misuse: Focus on Vascular Dysfunction

  42. 2022

    Dynamic Changes in the Endocannabinoid System during the Aging Process: Focus on the Middle-Age Crisis

    FavorávelEstudo em AnimaisLongevidadeAnandamida (AEA)Endocanabinoide (não especificado)+1
  43. 2022

    E-Cigarette and Cannabis Use Patterns, Depression, and Suicide Behaviors Among US Youth: Analysis of 2019 Youth Risk Behavior Survey Data

  44. 2022

    E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

    DesfavorávelMetanáliseCâncerAnsiedadeDoenças Cardiovasculares (DCV)+17
  45. 2022

    Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia

  46. 2022

    Editorial: Early Cannabis Exposure Definitions That Correspond With High Cumulative Lifetime Dose During Adolescence Are the Strongest Predictors of Adverse Health Outcomes

  47. 2022

    Effect Compartment Model for the Evaluation of Tolerance to Psychological Highness Following Smoking Marijuana

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  48. 2022

    Effect of antimicrobial photodynamic therapy with different photosensitizers and adhesion protocol on the bond strength of resin composite to sound dentin

    FavorávelEstudo LaboratorialInfecções BacterianasFicocianina
  49. 2022

    Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein

    FavorávelEstudo LaboratorialCOVID-19
  50. 2022

    Effect of Cannabidiol on the Neural Glyoxalase Pathway Function and Longevity of Several C. elegans Strains Including a C. elegans Alzheimer's Disease Model

    FavorávelEstudo LaboratorialDoença de AlzheimerLongevidade
  51. 2022

    Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial

    InconclusivoEnsaio ClínicoDorDependência — CannabisAnsiedade+5
  52. 2022

    Effect of the MAGL/FAAH Dual Inhibitor JZL-195 on Streptozotocin-Induced Alzheimer's Disease-like Sporadic Dementia in Mice with an Emphasis on Aβ, HSP-70, Neuroinflammation, and Oxidative Stress

  53. 2022

    Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study

    FavorávelEnsaio ClínicoInflamaçãoCOVID-19Anandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  54. 2022

    Effectiveness and Tolerability of Dronabinol Use in Patients with Chronic Pain: A Retrospective Analysis of 12-Week Open-Label Real-World Data Provided by the German Pain e-Registry

  55. 2022

    Effectiveness of Nutritional Ingredients on Upper Gastrointestinal Conditions and Symptoms: A Narrative Review

    FavorávelMetanáliseNáusea e VômitoRefluxo Gastroesofágico
  56. 2022

    Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10-14 year-olds: a pragmatic randomised controlled trial

  57. 2022

    Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+1
  58. 2022

    Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof-of-concept, randomized, placebo-controlled trials

    InconclusivoEnsaio ClínicoAnsiedadeAyahuasca
  59. 2022

    Effects of brief substance use interventions delivered in general medical settings: a systematic review and meta-analysis

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDependência — Álcool
  60. 2022

    Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review

    FavorávelMetanáliseAnsiedadeEpilepsiaObesidadeTetraidrocanabinol (THC)+6
  61. 2022

    Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasDoença de Parkinson
  62. 2022

    Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeEpilepsiaTetraidrocanabinol (THC)+2
  63. 2022

    Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeTEPT
  64. 2022

    Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases

    DesfavorávelEnsaio Clínico VeterinárioInflamaçãoAplicações VeterináriasDoenças de Pele+1
  65. 2022

    Effects of Cannabis in Parkinson's Disease: A Systematic Review and Meta-Analysis

    FavorávelMetanálise ClínicaDoença de Parkinson
  66. 2022

    Effects of endocannabinoid system modulation on social behaviour: A systematic review of animal studies

  67. 2022

    Effects of Epidiolex® (Cannabidiol) on seizure-related emergency department visits and hospital admissions: A retrospective cohort study

    FavorávelMetanáliseEpilepsiaCBD Farmacêutico
  68. 2022

    Effects of hemp seed alone and combined with aerobic exercise on metabolic parameters, oxidative stress, and neurotrophic factors in young sedentary men

    FavorávelEnsaio Clínico Duplo-CegoEstresse OxidativoSíndrome MetabólicaExercício Físico
  69. 2022

    Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19

  70. 2022

    Effects of Omega-3 Supplementation on Components of the Endocannabinoid System and Metabolic and Inflammatory Responses in Adipose and Liver of Peripartum Dairy Cows

    InconclusivoEstudo em AnimaisInflamaçãoObesidadeAnandamida (AEA)Outros Compostos Relacionados+1
  71. 2022

    Effects of oral cystine and glutamine on exercise-induced changes in gastrointestinal permeability and damage markers in young men

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoProteína Ligadora de Ácidos Graxos (FABP)Exercício Físico
  72. 2022

    Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review

    DesfavorávelMetanálise ClínicaEfeitos Adversos da CannabisPsicose
  73. 2022

    Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes

    FavorávelEstudo LaboratorialDoenças de PeleAnandamida (AEA)Endocanabinoide (não especificado)+8
  74. 2022

    Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoAnandamida (AEA)Tetraidrocanabinol (THC)+4
  75. 2022

    Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis

    FavorávelMetanálise ClínicaDisfunção CognitivaEsclerose MúltiplaTHC:CBD Farmacêutico
  76. 2022

    Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.)

    FavorávelEstudo LaboratorialCâncerEpilepsiaDoença de ParkinsonCanabigerol (CBG)Canabinol (CBN)+5
  77. 2022

    Effects of substance use disorder on oxidative and antioxidative stress markers: A systematic review and meta-analysis

    DesfavorávelMetanáliseDependência QuímicaInflamaçãoDependência — Cannabis+4
  78. 2022

    Effects of synthetic (JWH-018) cannabinoids treatment on spermatogenesis and sperm function

  79. 2022

    Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving

  80. 2022

    Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis

    FavorávelMetanálise ClínicaEpilepsiaEpilepsia — Síndrome de Dravet
  81. 2022

    Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis

    FavorávelMetanálise ClínicaEpilepsiaEpilepsia — Lennox-Gastaut
  82. 2022

    Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial

    FavorávelEnsaio ClínicoEpilepsiaSíndrome de RettCanabidivarina (CBDV)
  83. 2022

    Efficacy of a Mobile App-Based Coaching Program for Addiction Prevention among Apprentices: A Cluster-Randomized Controlled Trial

  84. 2022

    Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: A systematic review

    FavorávelMetanálise ClínicaCâncerAnorexia (perda de apetite)CaquexiaTHC Farmacêutico+1
  85. 2022

    Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials

    FavorávelMetanálise ClínicaEsclerose MúltiplaDoença de ParkinsonAVC+2
  86. 2022

    Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review

    FavorávelMetanálise ClínicaDorDor — Crônica
  87. 2022

    Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap

  88. 2022

    Electroacupuncture Reduces Anxiety Associated With Inflammatory Bowel Disease By Acting on Cannabinoid CB1 Receptors in the Ventral Hippocampus in Mice

    FavorávelEstudo em AnimaisAnsiedadeDII — Doença Inflamatória IntestinalAcupuntura (MTC)
  89. 2022

    Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease

  90. 2022

    Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption

  91. 2022

    Endocannabinoid metabolism inhibition ameliorates ovalbumin-induced allergic airway inflammation and hyperreactivity in Guinea pigs

  92. 2022

    Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty

  93. 2022

    Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells

  94. 2022

    Endocannabinoid signaling in glioma

  95. 2022

    Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis

    FavorávelEstudo em AnimaisFibroseDPOCFibrose — PulmonarEndocanabinoide (não especificado)
  96. 2022

    Endocannabinoid system contributions to sex-specific adolescent neurodevelopment

  97. 2022

    Endocannabinoid System in Polycystic Kidney Disease

  98. 2022

    Endocannabinoids and aging-Inflammation, neuroplasticity, mood and pain

  99. 2022

    Endoplasmic Reticulum Stress and Impairment of Ribosome Biogenesis Mediate the Apoptosis Induced by Ocimum x africanum Essential Oil in a Human Gastric Cancer Cell Line

    FavorávelEstudo LaboratorialCâncerCâncer — Estômago
  100. 2022

    Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story?